darifenacin hydrobromide

FDA Drug Profile

Drug Details

Generic Name
darifenacin hydrobromide
Brand Names
N/A
Application Number
Sponsor
Jubilant Biosys limited
NDC Codes
1
Dosage Forms
POWDER
Routes
N/A
Active Ingredients
DARIFENACIN

Indications and Usage

1 INDICATIONS AND USAGE Darifenacin extended-release tablets are indicated for the treatment of overactive bladder with symptoms of urge urinary incontinence, urgency and frequency. ( 1 ) Darifenacin extended-release tablets are indicated for the treatment of overactive bladder with symptoms of urge urinary incontinence, urgency and frequency.